Table of Contents
1. Introduction2. Application of CQDs in anti-cancer drug delivery
3. Nucleus-targeted anti-cancer drug delivery from CQDs
4. pH-responsive anti-cancer drug delivery from CQDs
5. Photothermal therapy from CQDs
6. Photodynamic therapy from CQDs
7. Challenges of CQD-based therapy in cancer treatment
8. Summary and future directions
Authors
N.K Jain Professor of Pharmaceutics (Ex), Department of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar, India.Prof. N.K. Jain is an internationally renowned academician and researcher and a senior professor in India who superannuated in June 2014 after rendering more than 40 years of dedicated and distinguished service as a teacher and 25 years as full professor. Prof. Jain is the author of two dozen celebrated books in pharmaceutical sciences in India and has contributed several chapters in national and international books. He has to his credit over 480 publications in reputed pharmaceutical Journals and has supervised 55 PhD and 141 M. Pharm. candidates. He has been a reviewer for several international and national research journals. Professor Jain's current research interests include various aspects of controlled, novel and targeted drug delivery; nanotechnology and nanomedicine and he is globally known for his excellent research in the field of hydrotropic solubilization, resealed erythrocytes-based drug delivery and dendrimer drug delivery. Currently he is exploring the pharmaceutical potential of Carbon Nanotubes and Quantum Dots.
Naveneet Dubey Indian Institute of Science Education and Research, Bhopal (IISERB), India.Dr. Naveneet Dubey is a postdoctoral fellow at the Indian Institute of Science Education and Research, Bhopal (IISERB), India. He received his Ph.D. from the School of Pharmaceutical Sciences at Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, India. Dr. Dubey's research focuses on carbon-based nanomaterials and drug delivery systems aimed at improving cancer therapies. Notable publications include studies on glucose-derived carbon dots and pH-responsive carriers for targeted chemotherapy. Dr. Dubey has presented research at major conferences like the International Conference on Drug Discovery and APTICON.
Recognized with awards such as the Research Excellence Award in Drug Delivery (RB Lifescience, 2022) and the Young Scientist Award (Madhya Pradesh Council of Science & Technology, 2023), Dr. Dubey has also secured funding from prestigious organizations like the Royal Society of Chemistry. With two patents and ongoing innovations in nanomedicine, Dr. Dubey is contributing significantly to pharmaceutical sciences and cancer treatment advancements.
